What do analysts expect the price target to be for BRIGHTCOVE (BCOV)?
7 analysts have analysed BCOV and the average price target is 4.54 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 4.45.
BRIGHTCOVE (BCOV) Forecast, Price Target & Analyst Ratings
NASDAQ:BCOV • US10921T1016
Current stock price
4.45 USD
+0.01 (+0.23%)
At close:
4.45 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BRIGHTCOVE (BCOV).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Feb 20, 2025
- Period
- Q4 / 2024
- EPS Estimate
- -$0.01
- Revenue Estimate
- 49.427M
Price Target Details & History
Consensus Price Target and Range
Mean target
$4.54
Upside
+ 2.00%
From current price of $4.45 to mean target of $4.54, Based on 7 analyst forecasts
Low
$4.49
Median
$4.54
High
$4.67
Price Target Revisions
1 Month
0.00%
3 Months
14.84%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for BCOV. The average price target is 4.54 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 4.45.
The average price target has been revised upward by 14.84% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
BCOV was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about BCOV.
In the previous month the buy percentage consensus was at a similar level.
BCOV was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-11-25 | Rosenblatt | Downgrade | Buy -> Neutral |
| 2024-11-05 | Lake Street | Upgrade | Hold -> Buy |
| 2024-02-23 | Lake Street | Downgrade | Buy -> Hold |
| 2024-02-23 | Rosenblatt | Maintains | Buy -> Buy |
| 2023-08-03 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-08-01 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-07-31 | Lake Street | Upgrade | Hold -> Buy |
| 2023-06-12 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-05-31 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-05-04 | Lake Street | Maintains | Hold |
| 2023-04-26 | Rosenblatt | Reiterate | Buy |
| 2023-02-24 | Rosenblatt | Reiterate | Buy |
| 2023-02-13 | Rosenblatt | Upgrade | Neutral -> Buy |
| 2022-09-09 | Rosenblatt | Initiate | Neutral |
| 2022-02-17 | Lake Street | Downgrade | Buy -> Hold |
| 2021-10-28 | Northland Capital Markets | Downgrade | Outperform -> Market Perform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Feb 20, 2025
- Period
- Q4 / 2024
- EPS Estimate
- -$0.01
- Revenue Estimate
- 49.427M
- Revenue Q2Q
- -1.45%
- EPS Q2Q
- -125.50%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.39%
EPS (1 Month)
0.00%
EPS (3 Months)
50.00%
Next Earnings Summary
BCOV is expected to report earnings on 2/20/2025. The consensus EPS estimate for the next earnings is -0.01 USD and the consensus revenue estimate is 49.43M USD.
The next earnings revenue estimate has been revised downward by 0.39% in the past 3 months.
Full Analyst Estimates 2024 - 2025
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 211.1M 6.94% | 211M -0.05% | 201.187M -4.65% | 202.1M 0.45% | 205.22M 1.54% | |
| EBITDA YoY % growth | 14.22M 30.46% | 3.4M -76.09% | -1.986M -158.41% | 17.839M 998.24% | 20.047M 12.38% | |
| EBIT YoY % growth | 5.9M 168.18% | -7.3M -223.73% | -18.522M -153.73% | 1.131M 106.11% | 2.711M 139.70% | |
| Operating Margin | 2.79% | -3.46% | -9.21% | 0.56% | 1.32% | |
| EPS YoY % growth | 0.41 13.89% | 0.23 -43.90% | -0.05 -121.74% | 0.00 100.00% | 0.04 |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 -125.50% | 0.00 -100.00% | 0.01 151.00% | 0.02 2.00% | 0.01 200.00% |
| Revenue Q2Q % growth | 49.427M -1.45% | 50.397M -0.17% | 51.148M 3.86% | 51.788M 3.68% | 51.885M 4.97% |
| EBITDA Q2Q % growth | 3.768M -73.62% | 4.453M 91.20% | 5.059M -8.80% | 5.507M -55.57% | 5.028M 33.44% |
| EBIT Q2Q % growth | -263.67K 88.29% | 203.49K 107.86% | 735.42K 116.21% | 1.122M 140.01% | 650.25K 346.62% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BRIGHTCOVE / BCOV Forecast FAQ
What is the next earnings date for BCOV stock?
BRIGHTCOVE (BCOV) will report earnings on 2025-02-20, after the market close.
What are the consensus estimates for BRIGHTCOVE (BCOV) next earnings?
The consensus EPS estimate for the next earnings of BRIGHTCOVE (BCOV) is -0.01 USD and the consensus revenue estimate is 49.43M USD.